We will conduct early clinical studies on cancer and intractable diseases, regenerative medicine using iPS cells, and phase I trials in healthy volunteers.
Ki-CONNECT is an educational and research institute specializing in these tests. Ki-CONNECT members carry out original leading-edge research clinical research and contribute to the creation of future medical care by connecting patients who desire new medicines, pharmaceutical companies that develop medicines, and researchers who discover the seeds of medicines.
Such so-called early clinical development cannot function without an implementation system that crosses clinical departments and occupations. The Department of Early Clinical Development takes a central position among these areas.
We are aiming to contribute to future medical care with patients and healthy volunteers wishing to participate in new treatment clinical studies.